Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$3.92B |
| 2 |
Visa
V
|
+$551M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$406M |
| 4 |
UnitedHealth
UNH
|
+$395M |
| 5 |
Advanced Micro Devices
AMD
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.41B |
| 2 |
NVIDIA
NVDA
|
+$2.28B |
| 3 |
Microsoft
MSFT
|
+$2.02B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.83B |
| 5 |
Flutter Entertainment
FLUT
|
+$962M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Consumer Discretionary | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 4.81% |
| 5 | Communication Services | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Omega Flex
OFLX
$297M
| $298K | ﹤0.01% |
7,098
+648
| +10% | +$31.5K |
|
4027
Candel Therapeutics
CADL
$733M
| $298K | ﹤0.01% |
34,317
+5,629
| +20% | +$33.3K |
|
4028
First Trust Cloud Computing ETF
SKYY
$2.92B
| $298K | ﹤0.01% |
2,500
| – | – |
|
4029
Norwood Financial Corp
NWFL
$370M
| $297K | ﹤0.01% |
10,926
+1,139
| +12% | +$33.2K |
|
|
BLFY
4030
DELISTED
Blue Foundry Bancorp
BLFY
| $297K | ﹤0.01% |
30,231
+910
| +3% | +$9.48K |
|
4031
James River Group Holdings
JRVR
$208M
| $295K | ﹤0.01% |
60,643
+16,703
| +38% | +$92K |
|
|
QIPT
4032
DELISTED
Quipt Home Medical
QIPT
| $293K | ﹤0.01% |
95,916
+8,491
| +10% | +$22.9K |
|
4033
Sutro Biopharma
STRO
$401M
| $292K | ﹤0.01% |
15,881
-11,421
| -42% | -$349K |
|
|
PLL
4034
DELISTED
Piedmont Lithium
PLL
| $292K | ﹤0.01% |
33,431
-891
| -3% | -$10.5K |
|
4035
The Joint Corp
JYNT
$118M
| $291K | ﹤0.01% |
27,380
+1,771
| +7% | +$19.8K |
|
4036
ProShares Short VIX Short-Term Futures ETF
SVXY
$228M
| $291K | ﹤0.01% |
5,810
| – | – |
|
4037
ProKidney
PROK
$316M
| $290K | ﹤0.01% |
171,797
+25,476
| +17% | +$45.9K |
|
4038
Inhibrx
INBX
$1.2B
| $290K | ﹤0.01% |
18,841
+2,786
| +17% | +$42.4K |
|
4039
Eledon Pharmaceuticals
ELDN
$261M
| $288K | ﹤0.01% |
+70,000
| New | +$276K |
|
4040
Medifast
MED
$109M
| $285K | ﹤0.01% |
16,194
+2,127
| +15% | +$39.5K |
|
|
LINE
4041
Lineage Inc
LINE
$9.65B
| $285K | ﹤0.01% |
4,870
-172,833
| -97% | -$11.7M |
|
4042
Prime Medicine
PRME
$527M
| $285K | ﹤0.01% |
97,621
+12,924
| +15% | +$45.4K |
|
4043
Princeton Bancorp
BPRN
$281M
| $284K | ﹤0.01% |
8,258
+1,659
| +25% | +$60.8K |
|
4044
Medallion Financial
MFIN
$229M
| $284K | ﹤0.01% |
30,247
+4,184
| +16% | +$39K |
|
4045
Eos Energy Enterprises
EOSE
$1.22B
| $284K | ﹤0.01% |
58,378
+49,964
| +594% | +$162K |
|
4046
Amylyx Pharmaceuticals
AMLX
$2.26B
| $283K | ﹤0.01% |
74,845
-9,727
| -12% | -$45.8K |
|
4047
ADC Therapeutics
ADCT
$134M
| $282K | ﹤0.01% |
141,495
+13,756
| +11% | +$36K |
|
4048
LifeMD
LFMD
$169M
| $281K | ﹤0.01% |
56,773
+7,756
| +16% | +$40.7K |
|
4049
Compass Therapeutics
CMPX
$344M
| $280K | ﹤0.01% |
192,766
+22,521
| +13% | +$37.4K |
|
4050
Alta Equipment Group
ALTG
$214M
| $278K | ﹤0.01% |
42,479
+4,152
| +11% | +$28.9K |
|
Similar funds
Barclays's Q4 2024 Portfolio in Review
As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.
- Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
- Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
- Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
- Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
- Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
- Barclays opened 343 new positions and closed 348 in Q4 2024.
- Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.
Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.